Laman Utama068270 • KRX
add
Celltrion Inc
Tutup sebelumnya
₩197,200.00
Julat hari
₩200,000.00 - ₩207,000.00
Julat tahun
₩144,615.31 - ₩251,000.00
Permodalan pasaran
47.60T KRW
Bilangan Purata
560.82K
Nisbah P/E
44.21
Hasil dividen
0.36%
Dalam berita
Kewangan
Penyata Pendapatan
Hasil
Pendapatan bersih
| (KRW) | Dis 2025info | Perubahan T/T |
|---|---|---|
Hasil | 1.33T | 25.06% |
Perbelanjaan pengendalian | 383.06B | 10.26% |
Pendapatan bersih | 528.43B | 123.30% |
Margin untung bersih | 39.73 | 78.56% |
Pendapatan bagi setiap syer | 2.40K | 117.62% |
EBITDA | 537.36B | 95.28% |
Kadar cukai berkesan | -0.01% | — |
Kunci Kira-kira
Jumlah aset
Jumlah liabiliti
| (KRW) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pelaburan tunai dan jangka pendek | 1.24T | 8.40% |
Jumlah aset | 22.33T | 6.08% |
Jumlah liabiliti | 4.98T | 43.37% |
Jumlah ekuiti | 17.35T | — |
Syer tertunggak | 218.61J | — |
Harga kepada buku | 2.51 | — |
Pulangan pada aset | 5.42% | — |
Pulangan pada modal | 5.77% | — |
Aliran Tunai
Perubahan bersih dalam tunai
| (KRW) | Dis 2025info | Perubahan T/T |
|---|---|---|
Pendapatan bersih | 528.43B | 123.30% |
Tunai daripada operasi | 139.88B | -54.28% |
Tunai daripada pelaburan | -629.48B | -520.17% |
Tunai daripada pembiayaan | 754.75B | 429.67% |
Perubahan bersih dalam tunai | 309.21B | 1,200.88% |
Aliran tunai bebas | -160.53B | -362.61% |
Perihal
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Diasaskan
2002
Tapak web
Pekerja
1,074
